Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuit, Inc. - INTU

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in POET Technologies Inc. of Class Action Lawsuit and Upcoming Deadlines - POET

Clinical trial NCT06100939 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-10-01 → 2026-06-12 3. primary completion date: 2025-10-01 → 2026-05-27 4. enrollment: 400 → 396 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05318105 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-12-31 → 2026-04-07 3. primary completion date: 2026-09-30 → 2025-10-06 4. enrollment: 372 → 167 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07498140: collaborators added: First Lviv Medical Union.

Clinical trial NCT07652658 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-15 → 2026-06-11 3. completion date: 2028-09-18 → 2028-09-14 4. primary completion date: 2028-09-18 → 2028-09-14

Clinical trial NCT06921759 updates: 1. primary completion date: 2026-05-01 → 2026-05-13 2. enrollment: 206 → 221 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05082259 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-03-16 → 2026-12-01 3. primary completion date: 2026-03-16 → 2026-12-01

Clinical trial NCT07091019 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-11-15 → 2025-12-17 3. completion date: 2033-05-15 → 2033-04-20 4. primary completion date: 2033-05-15 → 2033-04-20

Clinical trial NCT05207709 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-03-01 → 2026-03-26 3. primary completion date: 2026-03-01 → 2026-03-26 4. enrollment: 456 → 61 participants 5. enrollment type: ESTIMATED → ACTUAL